Antimicrobial resistance - should we be concerned?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.2, 2001-02, pp. : 201-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Thiazolidinedione-Insulin Therapy: Should We Be Concerned About Safety?

By Scheen André J.

Drug Safety, Vol. 27, Iss. 12, 2004-01 ,pp. : 841-856

Adis International

Access to resources Recommend Favorite

Real-life Experience of Clinical Efficacy of Omalizumab Use in the MiddleEast: Should We Also Be Concerned About Parasites?

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 43-46

Bentham Science Publishers

Access to resources Recommend Favorite

Antimicrobial resistance - why do we have it and what can we do about it?

By Dougherty T.J. Pucci M.J. Bronson J.J. Davison D.B. Barrett J.F.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1707-1709

Informa Healthcare

Access to resources Recommend Favorite

Antimicrobial resistance − a global concern

Reactions Weekly, Vol. 1, Iss. 1377, 2011-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

Combating antimicrobial resistance in hospitals

By Roth V.R. Jarvis W.R.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 73-88

Informa Healthcare

Access to resources Recommend Favorite